Delivery Order SPE2DB20D3103-SPE2DB24FM2B3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $9,477.16 and a completion date of June 25, 2025. Amerisourcebergen is delivering 20,000 units/mL of PROCRIT, a medication used to treat anemia, under a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 40,000 units of PROCRIT (Epoetin alfa) 40,000 units/mL vials, with a ceiling value of $7,135.83 and an ultimate completion date of January 2, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation indicated. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.54 firm fixed-price contract is for the delivery of 40,000 units/mL of the drug PROCRIT, with a completion date of March 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. government agency Medical Supply Chain, which is part of the Defense Logistics Agency (DLA), awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $1,307.36 and is for the delivery of 20,000 units/mL vials of PROCRIT, a medication used to treat anemia. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the procurement of 10,000 units of the pharmaceutical product PROCRIT 10,000 UNITS/ML VIALML. The order has a ceiling value of $2,087.69 and is a firm fixed-price contract. The period of performance runs through July 15, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, with a focus on...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,764.16 delivery order contract is for the procurement of 40,000 units of PROCRIT (Epoetin alfa), a medication used to treat anemia. The contract has an ultimate completion date of July 7, 2022 and is a firm fixed-price delivery order. There was no set-aside designation for this award. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10,000 units of Procrit (Epoetin alfa) 10,000 units/mL vials. The $2,273.25 firm-fixed-price contract has an ultimate completion date of August 16, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM2B3Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROCRIT 40,000 units/mL vials, a medication used to treat anemia. The fixed-price contract has a ceiling value of $9,118.83 and a completion date of January 10, 2024. It is not designated as a set-aside contract. In addition to this delivery order, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 1/9/24 |